ATE226089T1 - Verwendung einer zubereitung enthaltend einen plasminogen-aktivator für die verbesserung der wundheilung - Google Patents

Verwendung einer zubereitung enthaltend einen plasminogen-aktivator für die verbesserung der wundheilung

Info

Publication number
ATE226089T1
ATE226089T1 AT95200208T AT95200208T ATE226089T1 AT E226089 T1 ATE226089 T1 AT E226089T1 AT 95200208 T AT95200208 T AT 95200208T AT 95200208 T AT95200208 T AT 95200208T AT E226089 T1 ATE226089 T1 AT E226089T1
Authority
AT
Austria
Prior art keywords
plasminogen activator
wound healing
preparation containing
improving wound
present
Prior art date
Application number
AT95200208T
Other languages
English (en)
Inventor
Johan Hendrikus Verheijen
Original Assignee
Tno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tno filed Critical Tno
Application granted granted Critical
Publication of ATE226089T1 publication Critical patent/ATE226089T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
AT95200208T 1995-01-27 1995-01-27 Verwendung einer zubereitung enthaltend einen plasminogen-aktivator für die verbesserung der wundheilung ATE226089T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95200208A EP0723782B1 (de) 1995-01-27 1995-01-27 Verwendung einer Zubereitung enthaltend einen Plasminogen-Aktivator für die Verbesserung der Wundheilung

Publications (1)

Publication Number Publication Date
ATE226089T1 true ATE226089T1 (de) 2002-11-15

Family

ID=8219975

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95200208T ATE226089T1 (de) 1995-01-27 1995-01-27 Verwendung einer zubereitung enthaltend einen plasminogen-aktivator für die verbesserung der wundheilung

Country Status (5)

Country Link
US (2) US5925350A (de)
EP (1) EP0723782B1 (de)
JP (1) JP3980088B2 (de)
AT (1) ATE226089T1 (de)
DE (1) DE69528573T2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI241197B (en) * 2001-06-29 2005-10-11 Shiseido Co Ltd Composite powder and external skin agent containing the same
US7067492B2 (en) * 2001-09-06 2006-06-27 Omnio Ab Method of promoting healing of a tympanic membrane perforation
US7202066B2 (en) * 2002-01-29 2007-04-10 Carrington Laboratories, Inc. Combination of a growth factor and a protease enzyme
WO2004009111A1 (ja) * 2002-07-19 2004-01-29 Santen Pharmaceutical Co., Ltd. 角膜上皮障害治癒促進剤
WO2005040194A2 (en) * 2003-10-24 2005-05-06 Ludwig Institute For Cancer Research Methods and compositions for pdgf-c activation and inhibition
US20070128685A1 (en) * 2005-07-01 2007-06-07 Rodolfo Faudoa Methods and compositions for cell culture
US20070003541A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
US20070004036A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for keratinocyte culture
IN2015MN00047A (de) 2012-07-05 2015-10-16 Hadasit Med Res Service
ES2523458B1 (es) * 2013-05-23 2015-07-15 José Manuel GALEANO SALVADOR Composición farmacéutica o cosmética para la regeneración y cicatrización de la piel

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU586306B2 (en) * 1985-12-16 1989-07-06 Ethicon Inc. Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator
US4929442A (en) * 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
US5364622A (en) * 1987-12-04 1994-11-15 Dr. Karl Thomae Gmbh Methods for preventing adhesions to organs and parts of organs by application of tissue plasminogen activator and hydroxyethylcellulose hydrogel
US5192743A (en) * 1992-01-16 1993-03-09 Genentech, Inc. Reconstitutable lyophilized protein formulation
DE4411143C2 (de) * 1994-03-30 1996-08-01 Immuno Ag Thrombosemittel

Also Published As

Publication number Publication date
JP3980088B2 (ja) 2007-09-19
DE69528573T2 (de) 2003-06-18
DE69528573D1 (de) 2002-11-21
JPH08253425A (ja) 1996-10-01
US6033664A (en) 2000-03-07
EP0723782B1 (de) 2002-10-16
US5925350A (en) 1999-07-20
EP0723782A1 (de) 1996-07-31

Similar Documents

Publication Publication Date Title
ATE512650T1 (de) Hydrogelwundverband und zugehöriges herstellungs- und benutzungsverfahren
ATE196604T1 (de) Zusammensetzung enthaltend pdgf und dexamethason zur förderung von gewebsreparatur und - regenerierung
ES2166783T3 (es) Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii.
DE69734661D1 (de) Foerderung der wundheilung durch chemisch modifizierte tetracycline
DE69627680T2 (de) Verwendung von Kohlenhydraten zur Förderung der Abschuppung der Haut
EP0383363A3 (de) Verwendung von Wundheilungsagentien
DE59911740D1 (de) Topisch anwendbare mittel gegen nagelpilzerkrankungen
DE69634430D1 (de) Formulierung fur die wundheilung mit menschlichem plasma fibronektin
PT646012E (pt) Cura de feridas e tratamento de perturbacoes fibroticas por tgfbeta-3
AU7625196A (en) Bandaging system
DE69528573T2 (de) Verwendung einer Zubereitung enthaltend einen Plasminogen-Aktivator für die Verbesserung der Wundheilung
ATE267578T1 (de) Verwendung mindestens eines hydroxystilben in einer zusammensetzung, die die abschuppung der haut fördern soll.
DE69330727D1 (de) Gefriergetrockneter Verband
DE69734405D1 (de) Verwendung von CS-866 (Olmersartan) zur Herstellung eines Medikaments für die Behandlung von Arteriosklerose
ATE223228T1 (de) Verwendung von latenz assoziierten peptiden in der herstellung eines medikaments zur verbesserung der wundheilung.
ATE79536T1 (de) Tamoxifen zur topischen verwendung.
DE69213057D1 (de) Stimulierung von Wundheilung mit 15-Keto-prostaglandinverbindungen
DE69535081D1 (de) Verwendung von Prostaglandin A oder dessen Derivaten zur Behandlung von Psoriasis
ES540447A0 (es) Un metodo de preparar un vendaje
GB2347625A (en) Agent for treating allergic or hypersensivity condition
DE69723725D1 (de) Verfahren zur herstellung von konzentrierten lösungen von fibronectin ohne puffer
AU589283B2 (en) Synergistic blood clot treatment composition comprising tissue plasminogen activator and a prostaglandin
DE69600367D1 (de) Verwendung von Sulfasalazin und/oder dessen aktiven Metaboliten zur Herstellung eines Arzneimittels zur Behandlung von venöser Insuffizienz und venösen Ulcera
DK277387A (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
DE69131058D1 (de) Verwendung einer therapeutischen Zusammensetzung zur Behandlung von Bronchitis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0723782

Country of ref document: EP

REN Ceased due to non-payment of the annual fee